Multiple Sclerosis Clinical Trials in New York, New York
18 recruitingNew York, New York
Showing 1–18 of 18 trials
Recruiting
Phase 1
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Multiple Sclerosis
AstraZeneca24 enrolled19 locationsNCT07224373
Recruiting
Phase 1
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting
Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)123 enrolled12 locationsNCT05285891
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Multiple SclerosisRelapsing Multiple Sclerosis
TG Therapeutics, Inc.500 enrolled85 locationsNCT06433752
Recruiting
Phase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Relapsing Multiple Sclerosis
TG Therapeutics, Inc.800 enrolled46 locationsNCT05877963
Recruiting
Phase 3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Multiple Sclerosis
Sanofi900 enrolled338 locationsNCT06141486
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Myasthenia GravisMultiple Sclerosis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company120 enrolled35 locationsNCT06220201
Recruiting
Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)156 enrolled22 locationsNCT04047628
Recruiting
Phase 2
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD54 enrolled7 locationsNCT06292923
Recruiting
Not Applicable
A Study of the MIND Diet for Persons With Multiple Sclerosis
Multiple Sclerosis
Icahn School of Medicine at Mount Sinai100 enrolled1 locationNCT06992115
Recruiting
Phase 1
Vancomycin Study in Multiple Sclerosis (MS)
Multiple Sclerosis
Icahn School of Medicine at Mount Sinai12 enrolled1 locationNCT05539729
Recruiting
Not Applicable
Noninvasive Vagal Nerve Stimulation
Multiple Sclerosis
NYU Langone Health30 enrolled1 locationNCT06816004
Recruiting
Phase 2
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
DepressionMultiple Sclerosis
NYU Langone Health170 enrolled1 locationNCT06901687
Recruiting
Genes and Environment in Multiple Sclerosis
Multiple Sclerosis
Columbia University5,000 enrolled5 locationsNCT01353547
Recruiting
NYSCF Scientific Discovery Biobank
Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting
Not Applicable
Task Specific Training for Advanced Multiple Sclerosis
Multiple Sclerosis
Hunter College of City University of New York15 enrolled1 locationNCT06506929
Recruiting
Eccentric Exercise and Fatigue in Multiple Sclerosis
FatigueMultiple Sclerosis
Hunter College of City University of New York30 enrolled1 locationNCT06505421
Recruiting
Effect of Cooling on Balance Performance in Multiple Sclerosis
Multiple Sclerosis
Hunter College of City University of New York30 enrolled1 locationNCT06094855